About Sanifit
Sanifit is a company based in Palma (Spain) founded in 2007 was acquired by Vifor Pharma Benelux in November 2021.. Sanifit has raised $127.72 million across 4 funding rounds from investors including Baxter, Edmond de Rothschild and Andera Partners. Sanifit operates in a competitive market with competitors including Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others.
- Headquarter Palma, Spain
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$127.72 M (USD)
in 4 rounds
-
Latest Funding Round
$82.1 M (USD), Series D
Jun 26, 2019
-
Investors
Baxter
& 11 more
-
Employee Count
Employee Count
-
Acquired by
Vifor Pharma Benelux
(Nov 22, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Unlock access to complete
Leadership Team
2 people
Operations Team
2 people
CSO Team
1 people
CMO Team
1 people
Product Management Team
1 people
Unlock access to complete
Funding Insights of Sanifit
Sanifit has successfully raised a total of $127.72M across 4 strategic funding rounds. The most recent funding activity was a Series D round of $82.1 million completed in June 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 4
- Last Round Series D — $82.1M
-
First Round
First Round
(21 Aug 2014)
- Investors Count 11
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2019 | Amount | Series D - Sanifit | Valuation | Caixa Capital Risc | |
| Sep, 2015 | Amount | Series C - Sanifit | Valuation | Ysios Capital | |
| Nov, 2014 | Amount | Grant - Sanifit | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sanifit
Sanifit has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Baxter, Edmond de Rothschild and Andera Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are focused on healthcare and multiple sectors.
|
Founded Year | Domain | Location | |
|
Columbus Venture Partners is focused on biotechnology investment funds.
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sanifit
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sanifit
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sanifit Comparisons
Competitors of Sanifit
Sanifit operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Portola Pharma, MyoKardia, Cellino, Arrakis Therapeutics and Tenaya Therapeutics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Therapeutics for cardiovascular and autoimmune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Specialized drugs are developed for genetic heart diseases.
|
|
| domain | founded_year | HQ Location |
Developer of autologous cell therapies
|
|
| domain | founded_year | HQ Location |
Provider of tools for the analysis of RNA structures
|
|
| domain | founded_year | HQ Location |
Regenerative and gene therapeutics for heart failure are developed.
|
|
| domain | founded_year | HQ Location |
Innovative pharmaceuticals for cardiovascular and metabolic diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sanifit
Frequently Asked Questions about Sanifit
When was Sanifit founded?
Sanifit was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Where is Sanifit located?
Sanifit is headquartered in Palma, Spain. It is registered at Palma, Balearic Islands, Spain.
Is Sanifit a funded company?
Sanifit is a funded company, having raised a total of $127.72M across 4 funding rounds to date.
What does Sanifit do?
Sanifit was founded in 2007 in Palma, Spain, and operates in the biopharmaceutical sector. Treatments for calcification disorders are developed, with SNF472 as the lead compound targeting cardiovascular calciphylaxis and end-stage renal disease in hemodialysis patients. The pipeline includes ASB-01 for oral tartar prevention, SNF671 tablets for bone health in osteoporosis, and Lit-Control, a device for renal lithiasis monitoring through urinary pH control.
Who are the top competitors of Sanifit?
Sanifit's top competitors include Tenaya Therapeutics, Cellino and MyoKardia.
Who are Sanifit's investors?
Sanifit has 12 investors. Key investors include Baxter, Edmond de Rothschild, Andera Partners, CSL Vifor, and Caixa Capital Risc.